Oxybutynin Chloride — Class III drug recall D-0996-2019
Terminated recall by Lannett Company Inc., reported 2019-03-20, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0996-2019 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Recalling firm | Lannett Company Inc., Seymour, IN, United States |
| Recall initiated | 2019-02-21 |
| Classified | 2019-03-12 |
| Reported by FDA | 2019-03-20 |
| Terminated | 2020-11-06 |
| Distributed | Nationwide (US) |
| Quantity | 14,448 bottles |
| Reason classes | specification failure |
| NDC | 62175-0270, 62175-0270-37, 62175-0270-41, 62175-0271, 62175-0271-37, 62175-0271-41, 62175-0272, 62175-0272-37, 62175-0272-41 |
| Lot numbers | 18226783A, 18232540A |
| Expiration dates | 2021-07, 2021-08 |
Product
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0996-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.